Article
Initiation of Oral Pre-exposure Prophylaxis Associated With Changes in Genital Tract T Cell Phenotypes in Women Exposed to HIV.
The Journal of infectious diseases - 2 Sept 2026
Warrier Lakshmi, Saito Ayumi, Graham Jessica B, Swarts Jessica L, Vick Sarah C, MacLean Finn, Potchen Nicole B, Cruz Talavera Irene, Tsegaye Adino Tesfahun, Thomas Katherine K, Chohan Bhavna H, Ngure Kenneth, Mugo Nelly, Lingappa Jairam R, Lund Jennifer M
Abstract excerpt
Oral tenofovir-based HIV-pre-exposure prophylaxis (PrEP), approved for use in preventing human immunodeficiency virus (HIV) infection, has been implicated in altering the immune landscape. We leveraged longitudinal samples from heterosexual couples with the male partner living with HIV and the female partner without HIV initiating PrEP after enrollment. Applying high parameter flow cytometry to cells from...
Read the complete abstract on PubMedTopics
- Humans
- Female
- Pre-Exposure Prophylaxis
- HIV Infections
- Anti-HIV Agents
